Furethidine

From WikiMD's WELLNESSPEDIA


Chemical structure of Furethidine

Furethidine is a synthetic opioid analgesic that was developed in the mid-20th century. It is part of the 4-phenylpiperidine class of opioids, which also includes drugs such as pethidine (also known as meperidine). Furethidine was primarily researched for its potential use in pain management, but it is not widely used in clinical practice today.

Chemical Properties[edit]

Furethidine is characterized by its chemical structure, which includes a piperidine ring with a phenyl group attached. The presence of the piperidine ring is a common feature among many opioid analgesics, contributing to their ability to bind to opioid receptors in the central nervous system.

Pharmacology[edit]

Furethidine acts as an agonist at the mu-opioid receptor, which is responsible for its analgesic effects. Like other opioids, it can produce effects such as analgesia, euphoria, and sedation. However, it also carries the risk of side effects such as respiratory depression, constipation, and potential for addiction.

Clinical Use[edit]

Although Furethidine was initially developed for use as an analgesic, it has not been widely adopted in medical practice. This is due in part to the availability of other opioids that are more effective or have a better safety profile. The use of Furethidine is limited, and it is not commonly found in modern pharmacopoeias.

Synthesis[edit]

The synthesis of Furethidine involves the chemical modification of the piperidine ring and the introduction of various functional groups to enhance its binding affinity to opioid receptors. The synthetic pathway is complex and requires specialized knowledge in organic chemistry.

Legal Status[edit]

Furethidine is classified as a controlled substance in many countries due to its potential for abuse and addiction. Its legal status varies, and it is subject to strict regulations regarding its manufacture, distribution, and use.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.